QualityStocks Stock Newsletters Archives - Page 346 of 1818

FridayDec 10, 2010 4:40 pm

RAM Energy Resources, Inc. (RAME) Closes on Sale of Texas Assets

RAM Energy Resources, Inc. reported that the company has closed on the sale of producing oil and gas assets in the United States. The transaction is part of the company’s strategic repositioning announced earlier in the year. RAM Energy Resources, Inc. sold the company’s properties in the Barnett Shale and Boonsville area to Milagro Producing, LLC, a private oil and gas company. The company paid $43.7 million in cash subject to closing adjustments. The deal closed on December 8, 2010. RAM Energy Resources, Inc. said that the company would use $16 million of the proceeds from the sale to pay…

FridayDec 10, 2010 3:03 pm

FlatWorld Acquisition (FTWAU.OB) Launches IPO at $10

FlatWorld Acquisition Corp. was recently organized to acquire and merge with an operating business in either the global business services sector or emerging Asian markets, including China and India. The company today announced the pricing of its initial public offering (IPO) of 2,200,000 units at a price of $10 per unit for gross proceeds of $22 million. Each unit of the IPO consists of one ordinary share and one warrant to purchase an additional ordinary share at $11. The company’s shares commenced trading on the OTCBB today under the ticker symbol "FTWAU.” Prior to today’s IPO, FlatWorld Acquisition received a…

FridayDec 10, 2010 3:01 pm

NewCardio, Inc. (NWCI.OB) Announces Positive Results from Cardiac Safety Research Consortium

NewCardio Inc. is a cardiac diagnostic and services company developing and marketing proprietary software technologies for the monitoring and diagnosis of cardiovascular disease, as well as cardiac safety assessment of drugs under development. The company today announced results from a blinded drug safety study conducted by the Cardiac Safety Research Consortium (CSRC) to evaluate the performance of QTinno™ on its "testing" ECG dataset. QTinno is New Cardio’s patented software technology used to assess drug cardiac toxicity in drug development. The CSRC study results demonstrate QTinno’s ability to accurately detect the control drug’s (moxifloxacin)-induced QT interval prolongation, as well as its…

FridayDec 10, 2010 2:19 pm

Medistem, Inc. (MEDS.PK) Shares Up Big on Stem Cell News

Medistem, Inc.'s stock is soaring today after the company released news of a peer-reviewed publication on its data for what the company believes is the world’s first “combination therapy” human stem cell protocol for a spinal cord injury. San Diego, California-based Medistem is a biotechnology company developing technologies related to adult stem cell extraction, manipulation, and use for treating inflammatory and degenerative diseases. The Company has filed an Investigational New Drug (IND) application with the FDA for use of its universal donor endometrial regenerative cells (ERC) for treatment of critical limb ischemia, an advanced form of peripheral artery disease. Medistem…

FridayDec 10, 2010 2:07 pm

Crimson Exploration Inc. (CXPO) Reports on Bossier Development Program in Texas

Crimson Exploration Inc. issued an operational update on its oil and gas activities in the United States, where the company is working to explore and develop the Bossier formation. Crimson Exploration Inc. reported the completion of the Gobi #1 H well at the Bruin Prospect area. The well was drilled to a total measured depth of approximately 18,000 feet, and initial production was reported at 11.7 million cubic feet of natural gas per day. The Gobi #1 H well is located in San Augustine, County, Texas, and Crimson Exploration Inc. has a 70% working interest. Crimson Exploration Inc. reported that…

FridayDec 10, 2010 2:01 pm

Ardent Mines Ltd. (ADNT.OB) Announces Two Key Appointments to Board Ahead of 2011 Mining Acquisitions and Uplisting

Ardent Mines, an exploration stage mineral developer in the process of resource acquisition and logistical infrastructure assembly, reported the appointments of two new members to the Company’s Board of Directors today, Mr. James Ladner and Mr. Luciano De Freitas Borges. CEO of ADNT, Leonardo Riera, took a moment to comment on the appointment of these two remarkable gentlemen, even characterizing the decision as a milestone for ADNT itself, due to the vast experiential knowledge and industry experience possessed by both. Riera went on to indicate that 2011 should see the close of several major mining acquisitions, a listing of ADNT…

FridayDec 10, 2010 12:44 pm

AgFeed Industries, Inc. (FEED) Video Chart for Friday, December 10, 2010

After a gap down in November, FEED is establishing a higher low and a base in the area of $2.40. Technical traders are on alert for the base to hold with an increase in buying pressure to push the stock north of the 20 day moving average. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

FridayDec 10, 2010 12:13 pm

Arena Pharmaceuticals, Inc. (ARNA) Begins Phase 1 Clinical Trial of APD811 for Pulmonary Arterial Hypertension

Arena Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing oral drugs that target G protein-coupled receptors in four major therapeutic areas. These areas are cardiovascular, central nervous system, inflammatory and metabolic diseases. The company announced today the initiation of dosing in a Phase 1 clinical trial of APD811, a novel oral drug candidate discovered by Arena that targets the prostacyclin receptor for the treatment of pulmonary arterial hypertension or PAH. The Phase 1 trial is planned to enroll up to 72 healthy adult volunteers and will evaluate the safety, tolerability and pharmacokinetics of single-ascending doses of…

FridayDec 10, 2010 10:00 am

CorMedix Inc. (CRMD) – Biotech and Value Coverage

Value investing has a variety of definitions. Often times it means buying a stock that is out of favor or is merely being overlooked by Wall Street for whatever reason. It can also mean that the parts of the company are actually worth more than the whole. In short, it means that by some valuation metric, the stock can be deemed inexpensive. CorMedix has the attributes of a value play based on: • Later Stage Product Candidates in Development • Upcoming Phase II Data 1H11 • Potential Initiation of Pivotal Phase III 1H11 • Revenue Potential in Europe 2H11 CorMedix…

FridayDec 10, 2010 9:26 am

Laufer Bridge Enterprises (LBGE.PK) Subsidiary Announces Official Launch of Cenergy Brand of Sports Nutrition Supplements

Creative Edge Nutrition Inc., a wholly owned subsidiary of Laufer Bridge Enterprises, Inc., announced yesterday the official launch of their Cenergy brand of sports nutrition supplements. These nutrition products have been scientifically formulated to enhance optimum performance that focuses on overall nutrition. They promote a healthier lifestyle and wellbeing. Creative Edge Nutrition, Inc. Senior Vice President, Paul Thomas, said, “Our goal at Cenergy is to provide a high quality lifestyle, valued priced nutritional products, supplements and energy drinks that are results driven. Because of our backgrounds and the research that went into the development of these products we firmly believe…

Site Search

Company Search

Category: QualityStocks Stock Newsletters